We are live on ! Find out more
YARW

Yarrow Bioscience, Inc. Common Stock
YARW

53 hedge funds and large institutions have $139M invested in Yarrow Bioscience, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

103% more capital invested

Capital invested by funds: $68.4M → $139M (+$70.6M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

64% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 11

18% more funds holding

Funds holding: 45 → 53 (+8)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

Holders
53
Holders Change
+8
Holders Change %
+17.78%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
11
Increased
18
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
+$6.22M
2
O
OrbiMed
New York
+$4.22M
3
MP
Mangrove Partners
Connecticut
+$3.74M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.52M
5
DM
Deerfield Management
New York
+$1.32M

Top Sellers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
-$5.23M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$1.06M
3
GPP
Great Point Partners
Connecticut
-$984K
4
AIM
Alambic Investment Management
California
-$696K
5
JP Morgan Chase
JP Morgan Chase
New York
-$576K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$308K – – –
Bank of America
27
Bank of America
North Carolina
$306K -$24K -1 -8%
PPA
28
Parametric Portfolio Associates
Washington
$303K +$144K +6 +120%
Goldman Sachs
29
Goldman Sachs
New York
$301K +$24K +1 +10%
Morgan Stanley
30
Morgan Stanley
New York
$280K -$360K -15 -60%
OAM
31
Oxford Asset Management
United Kingdom
$268K +$216K +9 New
TD Asset Management
32
TD Asset Management
Ontario, Canada
$226K – – –
Two Sigma Advisers
33
Two Sigma Advisers
New York
$221K +$72K +3 +60%
Wells Fargo
34
Wells Fargo
California
$184K +$72K +3 +75%
TCIM
35
TIAA CREF Investment Management
New York
$179K +$144K +6 New
Squarepoint
36
Squarepoint
New York
$157K +$48K +2 +50%
EGM
37
Engineers Gate Manager
New York
$147K +$120K +5 New
Ameriprise
38
Ameriprise
Minnesota
$141K – – –
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$126K – – –
Deutsche Bank
40
Deutsche Bank
Germany
$106K -$96K -4 -50%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$100K +$96K +4 New
ARTA
42
A.R.T. Advisors
New York
$99K +$96K +4 New
TA
43
Teachers Advisors
New York
$97K – – –
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$96K – – –
Ohio Public Employees Retirement System (OPERS)
45
Ohio Public Employees Retirement System (OPERS)
Ohio
$91K +$72K +3 New
Two Sigma Investments
46
Two Sigma Investments
New York
$85K -$216K -9 -75%
AIG
47
American International Group
New York
$49K – – –
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$27K – – –
Barclays
49
Barclays
United Kingdom
$27K +$24K +1 New
TRCT
50
Tower Research Capital (TRC)
New York
$21K -$48K -2 -67%
1
2
3

YARW Hedge Fund Activity: Q1 2019 in Review

53 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience, Inc. Common Stock (YARW) for Q1 2019, worth a combined $139M — up 103% from $68.4M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new YARW positions and 3 closed out — a net gain of 8 holders — while 18 added to existing stakes and 11 trimmed.

The largest buyer was First Manhattan, adding an estimated $6.22M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $5.23M sold.

  • 53 institutional investors held Yarrow Bioscience, Inc. Common Stock (YARW) as of Q1 2019, up from 45 in Q4 2018.
  • Funds reported $139M of Yarrow Bioscience, Inc. Common Stock stock for Q1 2019, up 103% quarter-over-quarter.
  • 11 funds opened new Yarrow Bioscience, Inc. Common Stock positions in Q1 2019 and 3 closed out, a net change of +8 holders.
  • The largest Yarrow Bioscience, Inc. Common Stock buyer in Q1 2019 was First Manhattan, an estimated $6.22M added.
  • The largest Yarrow Bioscience, Inc. Common Stock seller in Q1 2019 was Novo Holdings A/S, an estimated $5.23M sold.

Based on aggregated 13F filings for Q1 2019.